Quent Capital LLC Increases Stake in Cigna Group $CI

Quent Capital LLC lifted its stake in Cigna Group (NYSE:CIFree Report) by 6.9% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 1,252 shares of the health services provider’s stock after acquiring an additional 81 shares during the period. Quent Capital LLC’s holdings in Cigna Group were worth $414,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of CI. Brighton Jones LLC raised its position in shares of Cigna Group by 9.3% in the 4th quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock valued at $1,032,000 after purchasing an additional 318 shares during the last quarter. NBC Securities Inc. purchased a new position in shares of Cigna Group in the 1st quarter valued at approximately $123,000. RFG Advisory LLC purchased a new position in shares of Cigna Group in the 1st quarter valued at approximately $233,000. Hennion & Walsh Asset Management Inc. raised its position in shares of Cigna Group by 13.5% in the 1st quarter. Hennion & Walsh Asset Management Inc. now owns 1,212 shares of the health services provider’s stock valued at $399,000 after purchasing an additional 144 shares during the last quarter. Finally, Signal Advisors Wealth LLC raised its position in shares of Cigna Group by 106.2% in the 1st quarter. Signal Advisors Wealth LLC now owns 1,827 shares of the health services provider’s stock valued at $601,000 after purchasing an additional 941 shares during the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Cigna Group

In related news, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the sale, the insider owned 25,648 shares of the company’s stock, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.70% of the company’s stock.

Analyst Ratings Changes

A number of research firms have issued reports on CI. Truist Financial set a $375.00 price target on shares of Cigna Group in a research report on Tuesday, September 2nd. TD Cowen raised shares of Cigna Group to a “strong-buy” rating in a research report on Monday, June 23rd. Guggenheim reissued a “buy” rating and set a $350.00 price target (down from $388.00) on shares of Cigna Group in a research report on Monday, August 4th. Wall Street Zen lowered shares of Cigna Group from a “buy” rating to a “hold” rating in a research report on Friday. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Cigna Group in a research report on Saturday, September 27th. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, Cigna Group currently has an average rating of “Moderate Buy” and an average price target of $371.81.

View Our Latest Research Report on CI

Cigna Group Price Performance

Shares of NYSE CI opened at $311.24 on Friday. The stock has a market capitalization of $83.08 billion, a price-to-earnings ratio of 16.99, a PEG ratio of 0.91 and a beta of 0.45. Cigna Group has a 12 month low of $256.89 and a 12 month high of $358.88. The firm’s 50 day simple moving average is $292.41 and its 200-day simple moving average is $309.73. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71.

Cigna Group (NYSE:CIGet Free Report) last issued its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, topping analysts’ consensus estimates of $7.15 by $0.05. The business had revenue of $67.13 billion for the quarter, compared to analysts’ expectations of $62.61 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The business’s revenue was up 11.0% on a year-over-year basis. During the same quarter last year, the company earned $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Analysts expect that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th were paid a dividend of $1.51 per share. The ex-dividend date of this dividend was Thursday, September 4th. This represents a $6.04 dividend on an annualized basis and a dividend yield of 1.9%. Cigna Group’s dividend payout ratio (DPR) is presently 32.97%.

Cigna Group Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Further Reading

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.